Global COVID-19 Vaccine

Global COVID-19 Vaccine Market Research Report: Forecast (2021-2026)

By Vaccine Type (Whole-microbe COVID-19 Vaccine [Inactivated COVID-19 Vaccine, Live Attenuated COVID-19 Vaccine, Viral Vector-Based COVID-19 Vaccine], Protein Subunit-Based COVID-19 Vaccine, Genetic A Read more

  • Healthcare
  • Apr 2021
  • 204
  • HC22064

Market Overview

The COVID-19 vaccine protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by developing an immune response against it.

As per the MarkNtel Advisors' research report, "Global COVID-19 Vaccine Market Analysis, 2021," the market is expected to witness exponential growth in the anticipated timeline. The outburst of the COVID-19 across the globe has endangered millions of lives.

According to WHO, around 2.9 million people died due to COVID-19, which has infused the strong demand for the coronavirus vaccine worldwide. The factors, such as the massive expenditure made by government & private firms toward vaccine development, increasing healthcare expenditure by the countries, and a significant rise in the number of COVID-19 patients, are backing the market growth. Moreover, surging investments in R&D activities, snowballing demand for Covid-19 vaccines, and fast approvals for vaccine trials by health agencies can also promote market growth over the forecast period.

Report Coverage Details
Study Period Historical Data: 2016-19
Base Year: 2020
Forecast Period: 2021-26
Regions Covered North America: USA, Canada, Mexico
Europe: Germany, UK, France, Italy, Spain, Russia
Asia-Pacific: China, India, Japan, South Korea, Australia and Others
South America:  Brazil, Rest of South America
Middle East & Africa:  UAE, Saudi Arabia, South Africa
Key Companies Profiled AstraZeneca Plc, Johnson & Johnson Inc, Novavax, BioNTech, Moderna, Glaxo Smith Kline Plc, CSL Ltd., Abbott Laboratories, Daiichi Sankyo Company Ltd, Astellas Pharma Inc., Pfizer, Bharat Biotech, Serum Institute of India
Unit Denominations USD Million/Billion

 

Market Segmentation

Senior Citizens Acquired Significant Market Share

Based on Patient Class, Senior Citizens acquired a significant part in the Global COVID-19 Vaccine market in 2020. Due to weak immunity and a higher risk of getting severe illnesses, senior citizens are more prone to COVID-19.

Around 78% of the people aged 65 and above died due to COVID-19. Adhering to this, governments introduced various vaccination drives with priority orders that included adults of 65 years and above to be the first groups to receive COVID-19 vaccines, reveals MarkNtel Advisors' in their research report, "Global COVID-19 Vaccine Market Analysis, 2021."

Whole-microbe Approach Witnessing Rapid Growth

In terms of Vaccine Type, the Whole-microbe approach is witnessing rapid growth in the Global COVID-19 Vaccine market. The segment further fragments into Inactivated, Live Attenuated, and Viral Vector-Based COVID-19 Vaccines wherein the inactivated vaccine acquired a considerable market share.

An inactivated vaccine uses viruses that cannot replicate because the genetic material gets destroyed. It then induces a potent antibody to build immune memory so that the body can stay protected against SARS-CoV-2 in the future. Companies such as Sinovac and Sinopharm use inactivated vaccines. 

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
    4. Market Segmentation
  2. Preface
  3. Executive Summary
  4. Impact of COVID-19 on Global COVID-19 Vaccine Market
  5. Global COVID-19 Vaccine Market Government Regulations
  6. Global COVID-19 Vaccine Market Trends & Insights
  7. Global COVID-19 Vaccine Market Dynamics
    1. Growth Drivers
    2. Challenges
    3. Impact Analysis
  8. Global COVID-19 Vaccine Market Hotspot & Opportunities
  9. Global COVID-19 Vaccine Market Analysis 2021-2026F
    1. Market Size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Vaccine Type
        1. Whole-microbe COVID-19 Vaccine
          1. Inactivated COVID-19 Vaccine
          2. Live Attenuated COVID-19 Vaccine
          3. Viral Vector-Based COVID-19 Vaccine
        2. Protein Subunit COVID-19 Vaccine
        3. Genetic Approach (Nucleic Acid Vaccine)
      2. By Patient Class
        1. Senior Citizens
        2. Adults
        3. Paediatrics
      3.  By End User
        1. Academic & Research Institutes
        2. Vaccination Centres
        3. Clinics
        4. Hospitals
        5. Others
      4. By Region
        1. North America
        2. South America
        3. Europe
        4. Middle East & Africa
        5. Asia Pacific
  10. North America COVID-19 Vaccine Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Vaccine Type
      2. By Patient Class
      3. By End Users
      4. By Country
        1. The US COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        2. Canada COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        3. Mexico COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
  11. South America COVID-19 Vaccine Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Vaccine Type
      2. By Patient Class
      3. By End Users
      4. By Country
        1. Brazil COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        2. Rest of South America COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
  12. Europe COVID-19 Vaccine Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Vaccine Type
      2. By Patient Class
      3. By End Users
      4. By Country
        1. UK COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        2. Germany COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        3. France COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        4. Italy COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        5. Spain COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        6. Russia COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        7. Rest of Europe COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
  13. Middle East & Africa COVID-19 Vaccine Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Vaccine Type
      2. By Patient Class
      3. By End Users
      4. By Country
        1. GCC COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        2. South Africa COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
  14. Asia Pacific COVID-19 Vaccine Market Outlook, 2021-2026F
    1. Market Size & Analysis
      1. Market Revenue
    2. Market Share & Analysis
      1. By Vaccine Type
      2. By Patient Class
      3. By End Users
      4. By Country
        1. India COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        2. China COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        3. Japan COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        4. South Korea COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
        5. Rest of Asia Pacific COVID-19 Vaccine Market Outlook, 2021-2026F
          1. Market Size & Analysis
            1. Market Revenue
          2. Market Share & Analysis
            1. By Vaccine Type
            2. By Patient Class
            3. By End User
  15. Global COVID-19 Vaccine Market Key Strategic Imperatives for Success & Growth
  16. Competition Outlook
    1. Competition Matrix
    2. Company Profiles (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
      1. AstraZeneca Plc
      2. Johnson & Johnson Inc.
      3. Novavax
      4. BioNTech
      5. Moderna
      6. Glaxo Smith Kline Plc
      7. CSL Ltd.
      8. Abbott Laboratories
      9. Daiichi Sankyo Company Ltd
      10. Astellas Pharma Inc.
      11. Pfizer
      12. Bharat Biotech
      13. Serum Institute of India 
  17. Disclaimer
Global COVID-19 Vaccine Market Segmentation
*This field is required